Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1999
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935813 Human pancreatitis-associated protein
08/10/1999US5935812 Polynucleotide
08/10/1999US5935811 Neuron-restrictive silencer factor nucleic acids
08/10/1999US5935810 Polynucleotide sequences coding a human weight regulatory protein; therapy and diagnostic tool for eating disorders cachexia; antisense agents; gene therapy
08/10/1999US5935809 Method of inducing plant defense mechanisms
08/10/1999US5935804 Method for detecting eubacteria in biological samples with catalytically inactive murein binding enzymes
08/10/1999US5935803 Methods to identify immunomodulators using cognate interaction of PKC-theta
08/10/1999US5935798 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
08/10/1999US5935797 Mixing proliferating cell nuclear antigen family of proteins and a major histocompatibility complex class ii alpha chain protein in presence and absence of a candidate agent, determining whether candidate agent blocks the binding
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/10/1999US5935789 Autonomously replicating sequences, GAPDH gene and promoter derived from Hansenula polymorpha, expression vectors containing same and method for the selection of transformants
08/10/1999US5935786 Methods for analyzing PRLTS DNA
08/10/1999US5935784 Prolactin receptor gene as a genetic marker for increased litter size in pigs
08/10/1999US5935783 Genes mapping in the digeorge and velocardiofacial syndrome minimal critical region
08/10/1999US5935782 Method and materials for detecting Legionella pneumophila
08/10/1999US5935778 Method for serological typing using type-specific antigens
08/10/1999US5935777 Culturing a selected host cell infected with a recombinant virus comprising a polynucleotide sequence encoding an entomopoxvirus thymidine kinase promoter sequence to construct a novel chimeric vaccines
08/10/1999US5935583 A vaccine strain of giardia which is cultured in media containing bile so as to produce a toxin in vitro for preventing or treating intestinal protozoal infections in an animal
08/10/1999US5935582 Hog cholera virus vaccine and diagnostic
08/10/1999US5935580 Recombinant adenylate cyclase of bordetella comprising at least one heterologous insert, such as an epitope at a permissive site within the n-terminal portion of the adneylate cyclase; and which exhibits invasive activity
08/10/1999US5935579 A peptide will stimulate proliferation of a t-cell clone in a t-cell proliferation assay and produce an alloepitopic effect, peptide when administered in a tolerizing amount will suppress proliferation of t-cell clone in second assay
08/10/1999US5935578 Contraceptive vaccine
08/10/1999US5935576 Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
08/10/1999US5935574 Saccharomyces-specific antigens and their use
08/10/1999US5935573 Hybrid protein
08/10/1999US5935570 Infecting a plant with a genetically transformed clavibacter that can synthesize a bioactive polypeptide, such as a rabies polypeptide; culturing the microorganism in the plant, oral administration of polypeptide to a mammal; vaccines
08/10/1999US5935569 Genetic anticancer vaccine
08/10/1999US5935568 Gene therapy for effector cell regulation
08/10/1999US5935567 Administering a polypeptide ip-10, or a suitable dna vector encoding the polypeptide ip-10
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999CA2136208C Improved methods for the preparation of endotoxin-binding proteins
08/10/1999CA2126863C Chimeric immunogens
08/10/1999CA2093434C Regulation of immunoglobulin production by interleukin-9
08/10/1999CA2070882C A process for large-scale production of antimicrobial peptide in high purity
08/10/1999CA2049449C Hla-dr antigen gene and its nucleotide sequence and its use
08/10/1999CA2002403C Injury-stimulated dna-sequence from solanum tuberosum and its use
08/10/1999CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use
08/10/1999CA1340703C Production of insulin-like growth factor binding protein
08/10/1999CA1340702C Derivatives of soluble t-4
08/10/1999CA1340698C Preparation and uses of interferon-gamma
08/10/1999CA1340696C Mammalian peptide expression in plant cells
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038990A1 Methods for recovering polypeptides from plants and portions thereof
08/05/1999WO1999038989A1 Constitutively active plant disease resistance genes and polypeptides
08/05/1999WO1999038987A1 METHOD FOR PRODUCING, BY PLANT CELLS, α1-ANTITRYPSIN AND ITS ALLELES, AND PRODUCTS CONTAINING THE RESULTING α1-ANTITRYPSIN
08/05/1999WO1999038985A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
08/05/1999WO1999038984A1 Process for producing peptide with the use of accessory peptide
08/05/1999WO1999038980A2 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
08/05/1999WO1999038978A1 Methods and reagents for decreasing allergic reactions
08/05/1999WO1999038977A2 Plant having altered environmental stress tolerance
08/05/1999WO1999038975A2 Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof
08/05/1999WO1999038974A1 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038972A2 Human genes and gene expression products ii
08/05/1999WO1999038971A1 Protein binding to midkine
08/05/1999WO1999038970A1 Placental protein 13
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038968A1 Recombinant proteins from hgf and msp
08/05/1999WO1999038967A2 Recombinant proteins derived from hgf and msp
08/05/1999WO1999038966A1 Wnt-10a
08/05/1999WO1999038965A1 Human hairless gene, protein and uses thereof
08/05/1999WO1999038959A1 Secreted proteins and polynucleotides encoding them
08/05/1999WO1999038955A2 Mutant herpes simplex viruses and uses thereof
08/05/1999WO1999038891A1 Multimeric erythropoietin with altered biological activity
08/05/1999WO1999038890A1 Erythropoietin with altered biological activity
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038888A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
08/05/1999WO1999038887A1 Divergent hiv-1 peptides
08/05/1999WO1999038886A1 Peptide structures and their use in diagnosis of herpes simplex virus type 2
08/05/1999WO1999038885A2 Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
08/05/1999WO1999038884A2 Method and means for site directed therapy
08/05/1999WO1999038882A1 Human cystatin f
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999038880A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999WO1999038526A1 Variant peptide ligands that selectively induce apoptosis
08/05/1999WO1999038525A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999WO1999038377A1 Transgenic mouse model
08/05/1999WO1999029718A3 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999028474A3 Chemokine variants and methods of use
08/05/1999WO1999028341A3 Maintenance of smooth muscle integrity by morphogenic proteins
08/05/1999WO1999027096B1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999023216A3 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/05/1999WO1999023116B1 ASSAY EMPLOYING CadC FUSION PROTEINS
08/05/1999WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants
08/05/1999WO1999021999A3 Wnt-1 inducible genes
08/05/1999WO1999020645A9 Vesicular amino acid transporter composition and method
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999020121A9 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue
08/05/1999WO1999019513A3 Methods for detecting compounds which modulate the activity of an lpa receptor
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999019357A3 Cell regulatory genes, encoded products, and uses related thereto
08/05/1999WO1999018210A3 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
08/05/1999WO1999018206A3 Human cancer antigen ny eso-1/cag-3 and gene encoding same
08/05/1999WO1999018202A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
08/05/1999WO1999018199A3 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS
08/05/1999WO1999017740A9 Peptide/lipid complex formation by co-lyophilization
1 ... 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 ... 2916